Prevention of thromboembolism in chronic atrial fibrillation

The prevention of thromboembolism in chronic atrial fibrillation refers to prophylactic therapeutic management aimed at reducing the risk of ischemic stroke and systemic arterial embolism in individuals with persistent or permanent cardiac supraventricular tachyarrhythmia In chronic atrial fibrillation, the loss of coordinated mechanical atrial contraction leads to blood stasis, endothelial dysfunction, and a hypercoagulable state—particularly within the left atrial appendage This circulatory st...

The prevention of thromboembolism in chronic atrial fibrillation refers to prophylactic therapeutic management aimed at reducing the risk of ischemic stroke and systemic arterial embolism in individuals with persistent or permanent cardiac supraventricular tachyarrhythmia In chronic atrial fibrillation, the loss of coordinated mechanical atrial contraction leads to blood stasis, endothelial dysfunction, and a hypercoagulable state—particularly within the left atrial appendage

The prevention of thromboembolism in chronic atrial fibrillation refers to prophylactic therapeutic management aimed at reducing the risk of ischemic stroke and systemic arterial embolism in individuals with persistent or permanent cardiac supraventricular tachyarrhythmia This circulatory stasis promotes intracardiac thrombus formation, which can dislodge into the arterial circulation and cause devastating end-organ infarction, most commonly affecting the cerebral vasculature

Clinical thromboembolic risk in this population is further amplified by advancing age and concurrent vascular comorbidities such as hypertension, diabetes mellitus, and heart failure

Clinical thromboembolic risk in this population is further amplified by advancing age and concurrent vascular comorbidities such as hypertension, diabetes mellitus, and heart failure